SiBone Pre-Tax Profit Margin 2017-2024 | SIBN
SiBone pre-tax profit margin from 2017 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| SiBone Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-12-31 | $0.17B | $-0.03B | -18.56% |
| 2024-09-30 | $0.16B | $-0.04B | -24.20% |
| 2024-06-30 | $0.15B | $-0.04B | -27.15% |
| 2024-03-31 | $0.14B | $-0.04B | -29.86% |
| 2023-12-31 | $0.14B | $-0.04B | -30.94% |
| 2023-09-30 | $0.13B | $-0.04B | -32.58% |
| 2023-06-30 | $0.12B | $-0.05B | -37.90% |
| 2023-03-31 | $0.12B | $-0.06B | -47.01% |
| 2022-12-31 | $0.11B | $-0.06B | -57.55% |
| 2022-09-30 | $0.10B | $-0.06B | -64.65% |
| 2022-06-30 | $0.10B | $-0.07B | -69.47% |
| 2022-03-31 | $0.09B | $-0.06B | -67.03% |
| 2021-12-31 | $0.09B | $-0.06B | -62.92% |
| 2021-09-30 | $0.09B | $-0.05B | -59.30% |
| 2021-06-30 | $0.08B | $-0.04B | -52.38% |
| 2021-03-31 | $0.08B | $-0.04B | -55.26% |
| 2020-12-31 | $0.07B | $-0.04B | -58.90% |
| 2020-09-30 | $0.07B | $-0.04B | -60.56% |
| 2020-06-30 | $0.07B | $-0.05B | -67.16% |
| 2020-03-31 | $0.07B | $-0.04B | -60.87% |
| 2019-12-31 | $0.07B | $-0.04B | -56.72% |
| 2019-09-30 | $0.06B | $-0.03B | -53.97% |
| 2019-06-30 | $0.06B | $-0.03B | -46.67% |
| 2019-03-31 | $0.06B | $-0.02B | -37.93% |
| 2018-12-31 | $0.06B | $-0.02B | -30.36% |
| 2018-06-30 | $0.04B | $-0.01B | -33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.595B | $0.167B |
| SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. | |||